# Arthur Kuan

> Arthur Kuan is a startup investor at CG Oncology. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [CG Oncology](https://shizune.co/investors/profile/cold-genesys)
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/arthurkuan

Arthur Kuan is a startup investor at CG Oncology. Arthur Kuan - Founding Member @ Ally Bridge Group

## About CG Oncology

VC Fund · Irvine, United States

CG Oncology formerly known as Cold Genesys is a privately-held, clinical-stage biopharmaceutical company focused on the research, acquisition, and development of novel immunotherapies. It specializes in the development of oncolytic immunotherapies to combat cancer, providing patients with new and impactful therapies.CG Oncology acquired therights to develop CG0070 from BioSante Pharmaceuticals (Nasdaq: BPAX). A phase I/IIa dose-escalating clinical trial has already completed in 35 patients with NMIBC. Cold Genesys is hopeful to get this therapy back into the clinical setting with the initiation of the proposed phase II/III trial.

5 contacts available at CG Oncology.

| Name | Title | Profile |
| --- | --- | --- |
| Alex Yeung | CEO | https://shizune.co/investors/profile/alex-yeung |
| Amy Steele | Vice President, Controller | https://shizune.co/investors/profile/amy-steele-amy-steele |
| Arthur Kuan | Chief Executive Officer | https://shizune.co/investors/profile/arthur-kuan |
| Bing Kung | Vice President of Business Development | https://shizune.co/investors/profile/bing-kung |
| Bradley Grimm | Director of Manufacturing | https://shizune.co/investors/profile/bradley-grimm |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co